MicroRNA in Lung Cancer Metastasis

por Wu, Shang-Gin, Chang, Tzu-Hua, Liu, Yi-Nan, Shih, Jin-Yuan
Publicado 2019

EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway

por Tsai, Meng-Feng, Chang, Tzu-Hua, Wu, Shang-Gin, Yang, Hsiao-Yin, Hsu, Yi-Chiung, Yang, Pan-Chyr, Shih, Jin-Yuan
Publicado 2015

IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer

por Wu, Shang-Gin, Chang, Tzu-Hua, Tsai, Meng-Feng, Liu, Yi-Nan, Hsu, Chia-Lang, Chang, Yih-Leong, Yu, Chong-Jen, Shih, Jin-Yuan
Publicado 2019

miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

por Liu, Yi-Nan, Tsai, Meng-Feng, Wu, Shang-Gin, Chang, Tzu-Hua, Tsai, Tzu-Hsiu, Gow, Chien-Hung, Wang, Hsin-Yi, Shih, Jin-Yuan
Publicado 2020

MiR‐503 pleiotropically regulates epithelial‐mesenchymal transition and targets PTK7 to control lung cancer metastasis

por Tsai, Tzu‐Hsiu, Gow, Chien‐Hung, Liu, Yi‐Nan, Tsai, Meng‐Feng, Chang, Tzu‐Hua, Wu, Shang‐Gin, Hsieh, Min‐Shu, Su, Kang‐Yi, Shih, Jin‐Yuan
Publicado 2023

LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis

por Chen, Yi-Ling, Liu, Yi-Nan, Lin, Yen-Ting, Tsai, Meng-Feng, Wu, Shang-Gin, Chang, Tzu-Hua, Hsu, Chia-Lang, Wu, Huey-Dong, Shih, Jin-Yuan
Publicado 2023

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

por Liu, Yi-Nan, Chang, Tzu-Hua, Tsai, Meng-Feng, Wu, Shang-Gin, Tsai, Tzu-Hsiu, Chen, Hsuan-Yu, Yu, Sung-Liang, Yang, James Chih-Hsin, Shih, Jin-Yuan
Publicado 2015